PATENT CLAIM ANALYSIS

Application Number: 16009943
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "218000"]

Abstract:
Disclosed are compounds of formula I as described herein, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of plasma kallikrein. Also disclosed are pharmaceutical compositions comprising at least one such compound, and methods involving use of the compounds and compositions in the treatment and prevention of diseases and conditions characterized by unwanted plasma kallikrein activity.

Claim (Index 151):
The compound of  claim 1 , wherein R 4  is cyclopropyl.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.4186
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15123059', '15764071', '10571212', '12774544', '13048832']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.83228194485255
- 35 USC 102 Novelty (BERT): 0.5886933336305553
- Combined Prediction Score: 0.8079230837303506
- Mean Citation Score: 406.383022
- Max Citation Score: 495.47354
- Similarity Product: 458.1563898973668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test